CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026

NEW YORK--(BUSINESS WIRE)--Aug 17, 2026--

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) and reminds investors of the August 17, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260817839374/en/

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Embecta knew or recklessly disregarded that the Company's guidance was misleading and unattainable. In fact, Embecta touted the Company's pen needle business as "incredibly resolute" mere weeks prior to missing expectations and cutting 2026 fiscal guidance.

On May 5, 2026, Embecta published second quarter 2026 fiscal results disclosing that the Company failed to meet its guidance for second quarter 2026 and lowered fiscal year 2026 guidance. In particular, Embecta revealed that revenue declined over 14%, much higher than the guidance of flat to a decline of 2% and that the Company was lowering estimates on US performance, largely in part due to weakness in its pen needle sales.

Following this news, the price of Embecta's common stock declined dramatically. From a closing market price of $9.25 per share on May 4, 2026, Embecta's stock price fell to $3.90 per share on May 5, 2026, a decline of over 57.8% in a single day.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Embecta’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Embecta class action, go to www.faruqilaw.com/EMBC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Embecta Securities Class Action Lawsuit:

What is the Embecta securities fraud lawsuit about?

Faruqi & Faruqi, LLP has filed a securities class action lawsuit alleging that Embecta Corp. (NASDAQ: EMBC) and certain of its officers and directors made materially false and misleading statements to investors during the Class Period. The lawsuit alleges that defendants concealed adverse facts concerning the true state of Embecta's financial results and that the Company's publicly issued guidance was misleading and allegedly unattainable. Specifically, the complaint alleges that Embecta touted its pen needle business as "incredibly resolute" just weeks before the Company missed its own guidance and was forced to cut its fiscal year 2026 outlook. On May 5, 2026, Embecta disclosed second quarter 2026 results showing a revenue decline of over 14% — far exceeding the guided range of flat to a decline of 2% — largely attributed to weakness in pen needle sales, causing the Company's stock price to fall approximately 57.8% in a single trading session. The lawsuit alleges that these circumstances caused investors to purchase Embecta securities at artificially inflated prices.

Who may be eligible to participate in the lawsuit?

Investors who purchased or otherwise acquired Embecta Corp. (NASDAQ: EMBC) securities on the NASDAQ between November 25, 2025 and May 4, 2026, inclusive, may be eligible to participate in this class action lawsuit. The lawsuit is brought on behalf of all such investors who allegedly suffered losses as a result of the conduct described in the complaint. Eligibility to participate in any potential recovery is not limited to those who seek appointment as lead plaintiff; all class members who purchased during the Class Period may be entitled to share in any recovery ultimately obtained. Investors who believe they may be eligible are encouraged to review their trading records for transactions in Embecta securities during the Class Period.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff is a court-appointed representative who leads the litigation on behalf of the entire class of similarly situated investors and works with counsel to make key decisions regarding the prosecution of the case. Under the Private Securities Litigation Reform Act of 1995, any investor who purchased Embecta securities during the Class Period may move the court to serve as lead plaintiff, and the court generally appoints the movant with the largest financial interest in the litigation who also satisfies applicable legal requirements. The deadline to file a motion for appointment as lead plaintiff is the lead plaintiff deadline applicable to this case, and investors wishing to seek this role should take action before that date. Importantly, investors do not need to serve as lead plaintiff in order to share in any recovery — class membership and potential recovery are available to all eligible investors regardless of whether they seek a leadership role in the litigation.

What should investors do if they purchased Embecta stock during the Class Period?

Investors who purchased Embecta Corp. (NASDAQ: EMBC) securities between November 25, 2025 and May 4, 2026, inclusive, are encouraged to promptly review their brokerage and trading records to confirm any purchases made during the Class Period. It is important to preserve all documentation related to those transactions, including trade confirmations, account statements, and any communications concerning Embecta securities, as such records may be relevant to establishing eligibility and assessing losses. Investors should evaluate their legal options in light of the pending lead plaintiff deadline, as certain procedural rights are time-sensitive. Faruqi & Faruqi, LLP is available to speak with investors, review their potential claims, and answer questions about the litigation process prior to the applicable deadline, with no obligation to serve as lead plaintiff in order to participate in any recovery.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Embecta securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026

NEWYORK (AP) — U.S. stocks are edging further from their record heights on Monday, ahead of a week where profit reports from the nation’s biggest retailers could give a hint about how shoppers are dealing with high inflation and a slowing job market.

The S&P 500 slipped 0.4% but remains near its all-time high set Thursday. The Dow Jones Industrial Average was down 284 points, or 0.5%, as of 2 p.m. Eastern time, and the Nasdaq composite was 0.3% lower.

Wall Street has run to records in large part because profits are booming for U.S. companies. Those in the S&P 500 index are on track to deliver growth of roughly 50% for earnings per share in the spring from a year earlier, according to FactSet. That’s much better than analysts expected and would be the best since five years ago, when the economy was erupting out of the chasm created by the COVID pandemic.

Nearly all the companies in the S&P 500 have turned in their profit reports for the spring. Still to come are big retailers, including reports this week from Home Depot, Target and Walmart.

They’re facing pressure. Their customers’ incomes may be turning iffier after U.S. employers surprisingly cut more jobs last month than they added. At the same time, their customers are continuing to see bills rise quickly as inflation remains much higher than anyone would like.

A report last week said that shoppers surprisingly spent less at U.S. retailers last month than in June, and CEOs for retailers could give color this week on what they’re seeing.

In the meantime, the wait continues for what the war with Iran will do with oil prices. The price for a barrel of Brent crude rose 2.4% to $90.62 Monday, and the losses for stocks solidified in the afternoon as the gains for oil prices accelerated.

Brent zigzagged between $72 and $102 last month as hopes rose and fell that the United States and Iran could reach a deal that would allow oil tankers to freely exit the Persian Gulf again.

In the bond market, Treasury yields ticked higher following their own big recent moves. The yield on the 10-year Treasury rose to 4.72% from 4.68% late Friday following a report showing stronger-than-expected growth in manufacturing in New York state.

The 10-year yield has shot up from 3.97% before the war with Iran, largely because higher oil prices raised the pressure on inflation and upped the probability that the Federal Reserve will have to hike interest rates.

Higher rates could keep a lid on inflation, but they do so by intentionally slowing the economy and making it more expensive for everyone to borrow money. The average long-term U.S. mortgage rate has already jumped near its highest level in a year because of the rise in the 10-year Treasury yield.

Reports last week, though, showed that inflation last month was not as bad as earlier in the summer. That raised hopes that the Fed could wait until later in the year before having to decide whether to raise its main interest rate.

Usually around this time of year, anticipation is building on Wall Street to hear from the head of the Federal Reserve about where interest rates may be heading. But the Fed's new chairman, Kevin Warsh, may give little insight at this year's economic symposium in Jackson Hole, Wyoming, at the end of this month, according to Thierry Wizman, a strategist at Macquarie Group

Warsh has been adamant about giving Wall Street less guidance about the Fed's plans for interest rates.

On Wall Street, trading was relatively quiet.

L3Harris Technologies fell 3.9% after the defense company said Christopher Kubasik stepped down as its CEO and chairman following “certain conduct by Kubasik that was not consistent with the values of the Company.” It gave few details but said the conduct was not related to its financial reporting, controls, customer relationships or operational performance.

Alphabet dipped 0.9% even though Berkshire Hathaway said it increased its investment in Google’s parent company, along with several homebuilders. Berkshire built a reputation for buying stocks at affordable prices under its former CEO, famed investor Warren Buffett.

Constellation Brands fell 5.7% after Berkshire said it sold all its holdings in the seller of Modelo beer and Robert Mondavi wine.

In stock markets abroad, indexes dipped in Europe following a stronger finish in Asia.

Tokyo's Nikkei 225 rose 0.7% after a report said Japan's economy grew at a slower pace in the April-June quarter than economists expected. Indexes jumped 1.3% in Hong Kong and 1.4% in Shanghai for some of the world’s biggest moves.

AP Business Writers Yuri Kageyama and Michelle Champan contributed to this report.

Earlier versions of this story incorrectly reported that Japan’s economy grew slightly faster than expected in the April-June quarter.

Specialist Michael Pistillo works on the floor of the New York Stock Exchange, Wednesday, Aug.. 5, 2026, in New York. (AP Photo/Yuki Iwamura)

People walk past the Nasdaq MarketSite, Thursday, Aug. 6, 2026, in New York. (AP Photo/Yuki Iwamura)

A general view shows the New York Stock Exchange, Friday, Aug. 7, 2026, in New York. (AP Photo/Yuki Iwamura)

People walk in the rain near electronic stock board showing Japan's Nikkei index at a securities firm Thursday, Aug. 13, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person walk in front of an electronic stock chart board showing Japan's Nikkei index at a securities firm Thursday, Aug. 13, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)